Zicix (OTCMKTS:ZICXD – Get Free Report) and HealthEquity (NASDAQ:HQY – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.
Risk and Volatility
Zicix has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500. Comparatively, HealthEquity has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500.
Valuation & Earnings
This table compares Zicix and HealthEquity”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Zicix | N/A | N/A | N/A | ($100.14) | -0.01 |
| HealthEquity | $1.31 billion | 5.64 | $215.20 million | $2.67 | 33.21 |
HealthEquity has higher revenue and earnings than Zicix. Zicix is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
99.6% of HealthEquity shares are held by institutional investors. 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Zicix and HealthEquity’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Zicix | N/A | N/A | N/A |
| HealthEquity | 17.25% | 14.75% | 9.22% |
Analyst Recommendations
This is a breakdown of current recommendations for Zicix and HealthEquity, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Zicix | 0 | 0 | 0 | 0 | 0.00 |
| HealthEquity | 1 | 1 | 11 | 1 | 2.86 |
HealthEquity has a consensus price target of $110.57, suggesting a potential upside of 24.70%. Given HealthEquity’s stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than Zicix.
Summary
HealthEquity beats Zicix on 12 of the 13 factors compared between the two stocks.
About Zicix
Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.
About HealthEquity
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
Receive News & Ratings for Zicix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zicix and related companies with MarketBeat.com's FREE daily email newsletter.
